Pathos AI Acquires Brain-Penetrant PRMT5 Inhibitor for Precision Cancer Therapy
Pathos AI has announced the acquisition of a worldwide license for PRT811, a SAM-competitive PRMT5 inhibitor, from Prelude Therapeutics. Renamed …
All Posts
Pfizer Appoints New Chief AI Officer to Enhance Digital Innovation
As Amber Jackson reports for Technology Magazine, Pfizer has appointed Berta Rodriguez-Hervas as its new Chief AI and Analytics Officer, …
Obesity R&D: The Making of a $100 Billion Market
Obesity has emerged as a focal point for drug development in recent years, driven by its growing prevalence across many …
23andMe Shifts Focus to Telehealth GLP-1 Prescriptions Amid Strategic Realignment
Consumer genetic testing company 23andMe has announced a strategic shift, closing its drug discovery division while expanding into the rapidly …
Six AI-driven Drug Discovery Companies Enabling Precision Oncology
Artificial Intelligence (AI) is steadily making its presence felt across various sectors, including the pharmaceutical industry. Among the multiple applications …
Medable Introduces New eCOA Platform to Streamline Clinical Trial Launches
Medable Inc., a technology platform provider specializing in clinical trials, has announced the launch of Medable Studio, an all-in-one application …
Basecamp Research Partners with Cameroon to Share Benefits from Genetic Data Use in Landmark Agreement
Basecamp Research, a London-based biotech company specializing in AI-driven design of proteins and other biological systems, has entered into a …
Veridix AI Introduces Protocol Digitization to Streamline Clinical Trial Study Builds
Veridix AI, a subsidiary of the Emmes Group, has unveiled its latest technological advancement aimed at enhancing the efficiency of …
OpenFold Consortium Expands with Six New Members to Strengthen Open-Source AI Tools for Drug Discovery
OpenFold, a prominent non-profit AI research consortium dedicated to developing free and open-source tools for biology and drug discovery, has …
Persist AI and Nivagen Collaborate on AI-Enhanced Manufacturing for Long-Acting Injectables
Persist AI and Nivagen have announced a strategic collaboration aimed at advancing the manufacturing process for long-acting injectable (LAI) drugs. …
Halda Therapeutics Secures $126 Million in Series B Extension to Advance RIPTAC Cancer Therapies
Halda Therapeutics, a biotechnology company specializing in cancer treatments, has announced the successful completion of a $126 million Series B …
Novel AI Framework for Detecting LLM "Hallucinations" in Medical Summaries
Mendel AI, a startup specializing in healthcare artificial intelligence (AI), in collaboration with the University of Massachusetts Amherst (UMass Amherst), …